Venizelos Warns: Energy Geopolitics Shakes the Eastern Mediterranean and Greece’s Strategic Interests
Greece at the crossroads of competing interests, forging new alliances, facing rivalries, and shaping energy routes that define the future.
ΠΑΡΑΣΚΕΥΗ
14
ΝΟΕΜΒΡΙΟΥ
SURVIVAL SECRETS
Ειδήσεις, video, ειδησεις τωρα και νέα για SURVIVAL SECRETS από το pagenews.gr
-
Venizelos Warns: Energy Geopolitics Shakes the Eastern Mediterranean and Greece’s Strategic Interests -
Papachelas: ND at a Crossroads – Survival of Its Core Base and Governmental Power at Stake
Papachelas: ND at a Crossroads – Survival of Its Core Base and Governmental Power at Stake
After declining social support and internal rifts, New Democracy must rebuild its base and design coalition strategies without losing the center.
-
Reverse Full Speed at ELTA: Government Under Fire Over Regional Post Office Closures
Reverse Full Speed at ELTA: Government Under Fire Over Regional Post Office Closures
Following intense backlash and internal party pressure, the Hellenic Post administration hits the brakes on its restructuring plan, freezing closures in regional areas.
-
Political Storm over Hellenic Post Closures – Pierrakakis Speaks of “Saving”, Opposition of “Dismantling”
Political Storm over Hellenic Post Closures – Pierrakakis Speaks of “Saving”, Opposition of “Dismantling”
ELTA shutdown ignites a political firestorm – Pierrakakis defends “difficult but necessary decisions”
-
Mitsotakis: “Attica Will Never Run Out of Water Again – €2.5 Billion Investment for Evrytos”
Mitsotakis: "Attica Will Never Run Out of Water Again – €2.5 Billion Investment for Evrytos"
With a €2.5 billion investment and the “Evrytos” project, the government secures Attica against drought for the next 30 years.
-
Το Enhertu των AstraZeneca-Daiichi Προσφέρει Νέες Ελπίδες Ίασης για Χιλιάδες Γυναίκες με Καρκίνο Μαστού
Το Enhertu των AstraZeneca-Daiichi Προσφέρει Νέες Ελπίδες Ίασης για Χιλιάδες Γυναίκες με Καρκίνο Μαστού
Τα Εντυπωσιακά Αποτελέσματα Δύο Μελετών στην ESMO 2025 Επιβεβαιώνουν την Αποτελεσματικότητα του Φαρμάκου σε Πρώιμο Στάδιο, Μειώνοντας τον Κίνδυνο Υποτροπής κατά 53%
